We are excited to announce that the abstract, The VENOS-2 Early Feasibility Study: Six-Month Outcomes of the Velocity® Percutaneous Arteriovenous Fistula System (NCT06712251) was presented by Bart Dolmatch, MD as a featured late breaking abstract at the recent SIR annual scientific meeting in Toronto.
